The Oncologist, 2026 Phase 1/2 study of INCAGN01876, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, plus immunotherapy for advanced cancers Hamid O., Forget F., Johnson M. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Nature Aging, 2026 Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset Yu S., Chen C., Feng J. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPatient StratificationPlasma | | | | |
Biological Psychiatry Global Open Science, 2026 Smoking interacts with APOE ε4 to influence dementia: evidence from UK biobank and validation by meta-analysis of longitudinal studies Cong Y., Wang Y., Huang L. et al. Olink Explore 3072/384NeurologyEnvironmental Health & ToxicologyPathophysiologyPlasma | | | | |
Journal of Immunology Research, 2026 Cytokine Changes With Effective Drug Therapy for Juvenile Myasthenia Gravis Geng Y., Liu P., Jin M. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
BMC Cancer, 2026 Exploration of plasma proteomic landscapes using Olink Reveal technology to identify biomarkers for early-stage/localized gastric cancer Ding S., Li X., Dong X. et al. RevealOncologyPatient StratificationPlasma | | | | |
International Journal of Women's Health, 2026 Causal Effects of Circulating Inflammatory Proteins on Postmenopausal Atrophic Vaginitis in European Populations: A Mendelian Randomization Study with Transcriptomic Validation Hu X., Ruan S., Zhong T. et al. Olink Target 96EndocrinologyGynecologyPathophysiologyPlasma | | | | |
Theranostics, 2026 Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast Cancer Yang J., Li Q., Zhao P. et al. Olink Target 48 MouseOncologyPathophysiologyMouse Serum | | | | |
Nature Medicine, 2026 Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS Ran X., Wuu J., Qin Z. et al. Olink Explore 3072/384Olink Explore HTNeurologyPatient StratificationPlasma | | | | |
Journal of Colloid and Interface Science, 2026 Introduction of optimized folate group modification on lipid-coated magnetic nanobeads enables targeting of folate receptor beta Schaaf M., Offer S., Zhang H. et al. Olink Target 96Respiratory DiseasesTechnical EvaluationCell Culture Supernatant | | | | |
npj Genomic Medicine, 2026 Circulating cell-free RNA signatures associate with plaque calcification in advanced carotid atherosclerosis Wei J., Lan T., Zhu Y. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Neurological Sciences, 2026 Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia Yao Y., Zou Q., Chen K. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
International Journal of Cardiology, 2026 Activation of the complement lectin pathway is associated with long-term cardiac dysfunction and incident heart failure in acute coronary syndrome patients Zhong B., King B., Mares R. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Allergy, 2026 Distinct Immunometabolic Profiles in Finnish and Russian Karelian Adolescents With Contrasting Allergy Risk Fyhrquist N., Riskumäki M., Karisola P. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture SupernatantSerum | | | | |
Proteomes, 2026 Proteomic Mediators Linking Autoimmune Diseases to Major Adverse Cardiovascular Events: Insights from the UK Biobank Huang J., Liu C., Sperling L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologyPatient StratificationPlasma | | | | |
Nature Genetics, 2026 Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk Pietzner M., Williamson A., Hunt K. et al. Olink Explore HTWider Proteomics StudiesCross-platform ValidationPlasma | | | | |
Immunity & Ageing, 2026 Reduced NK cell frequency in older patients with evolving fractures is linked to a distinct inflammatory cytokine profile Moch J., Kappes J., Jauregui R. et al. Olink Target 96AgingOrthopedicsPathophysiologyPlasma | | | | |
Annals of the Rheumatic Diseases, 2026 CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy Sun J., Hu X., Li W. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
Nature Communications, 2026 Absent pleocytosis in infant viral central nervous system infections reflects lymphocyte depletion and cytokine activation Mills C., Drummond H., Groves H. et al. Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma | | | | |
Brain, Behavior, & Immunity - Health, 2026 Plasma proteomic profile of inflammatory depressive symptoms Ängeby F., Ventorp F., Stiernborg M. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Brain, Behavior, & Immunity - Health, 2026 Plasma proteomic profile of inflammatory depressive symptoms Ängeby F., Ventorp F., Stiernborg M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |